Can a China DMF Be Amended After Submission?

Yes, a China Drug Master File (DMF) can be amended after submission. Amendments are typically required to update information, address regulatory changes, or correct errors. The holder must submit the revised sections to the National Medical Products Administration (NMPA) for review and approval, ensuring compliance with current regulatory requirements.

Leave a Reply

You must be logged in to post a comment.